
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Masonic Cancer Center, University of Minnesota"
Count: 268
Selected: 0
NCT ID | Title |
---|
NCT04629209 | A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma | ||
NCT03365661 | QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML | ||
NCT05708703 | Assessing the Time Demands of Cancer | ||
NCT04228952 | Metabolism of NNK in Japanese Americans | ||
NCT01158456 | Metabolism of NNK Among African Americans | ||
NCT03978117 | Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and Carcinogens | ||
NCT04630769 | FT516 and IL2 With Enoblituzumab for Ovarian Cancer | ||
NCT05502302 | App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer | ||
NCT04969783 | Telehealth-Filter Ventilation ( COMET2P1 ) | ||
NCT05735717 | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | ||
NCT02605421 | Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma | ||
NCT02661035 | Allo HSCT Using RIC for Hematological Diseases | ||
NCT06030648 | MT2022-01: MSCs for ALD | ||
NCT03678493 | A Study of FMT in Patients With AML Allo HSCT in Recipients | ||
NCT05447156 | QuitGuide for American Indians: Aims 2 & 3 | ||
NCT04714372 | FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia | ||
NCT05363267 | NF-1, Nutraceutical Intervention | ||
NCT03557749 | Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies | ||
NCT05973656 | Role of Acetaldehyde in the Development of Oral Cancer | ||
NCT05700630 | Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia | ||
NCT04003805 | Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users | ||
NCT02582775 | MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs | ||
NCT05338658 | Study of PAT in Patients With Solid Tumor Cancers | ||
NCT03050216 | QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML | ||
NCT05025774 | Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise | ||
NCT01666080 | Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) | ||
NCT04855253 | Study of E7777 Prior to Kymriah for R/R DLBCL | ||
NCT03674411 | Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy | ||
NCT05665543 | Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors | ||
NCT03850691 | Radiation and Combination Immunotherapy for Melanoma | ||
NCT05123040 | Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids | ||
NCT03998735 | Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure | ||
NCT03367546 | Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases | ||
NCT03125642 | Auto Stem Cell Transplant for Lymphoma Patients | ||
NCT02670837 | Study of Cellutome System for Treatment of Individual Lesions in EB Pts | ||
NCT00167219 | Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) | ||
NCT02666105 | Exemestane in Post-Menopausal Women With NSCLC | ||
NCT03946423 | BAriaTric Surgery After Breast Cancer Treatment (BATS) | ||
NCT03417154 | Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS | ||
NCT02988466 | Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT | ||
NCT05805605 | Allo HSCT Using RIC and PTCy for Hematological Diseases | ||
NCT03054909 | IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer | ||
NCT05708924 | MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
NCT03789721 | Adrenoleukodystrophy National Registry Study | ||
NCT05114837 | Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL | ||
NCT04882423 | Vegetable Intake Effect on Heterocyclic Amine Metabolism | ||
NCT05322408 | HCW9218 in Select Advanced Solid Tumors | ||
NCT05120570 | PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation | ||
NCT03934840 | CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone | ||
NCT03314974 | Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders |